ChemoCentryx

$57.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.22 (+2.18%) Today

$0.00 (0.00%) As of 7:19 AM EST after-hours

Why Robinhood?

You can buy or sell ChemoCentryx and other stocks, options, and ETFs commission-free!

About CCXI

ChemoCentryx, Inc. Common Stock, also called ChemoCentryx, is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in Mountain View, CA. The listed name for CCXI is ChemoCentryx, Inc. Common Stock.

CEO

Thomas J. Schall

Employees

Headquarters

Mountain View, California

Founded

1996

Market Cap

3.96B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

472.48K

High Today

$57.90

Low Today

$54.80

Open Price

$56.86

Volume

526.08K

52 Week High

$65.43

52 Week Low

$7.92

Collections

Analyst Ratings

100%

of 8 ratings

Buy

100%

Hold

Sell

CCXI Earnings

-$0.35

-$0.14

$0.08

$0.29

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Estimated

-$0.31 per share

Actual

-$0.35 per share

Replay Earnings Call